Molecular dynamics and virtual screening
Homology modeling, molecular dynamics, and virtual screening of NorA efflux pump inhibitors of <em>Staphylococcus aureus</em>
16
Identification of polyketide synthase 13 inhibitor: Pharmacophore-based virtual screening and molecular dynamics simulation
6
ENERGY BASED PHARMACOPHORE MODELING, VIRTUAL SCREENING, AND MOLECULAR DYNAMICS TO IDENTIFY POTENTIAL INHIBITORS FOR GLYCOGEN SYNTHASE KINASE 3 BETA
8
Virtual screening for potential inhibitors of Mcl-1 conformations sampled by normal modes, molecular dynamics, and nuclear magnetic resonance
11
Virtual screening and molecular dynamics simulation suggest Valproic acid Co-A could bind to SARS-CoV2 RNA depended RNA polymerase
10
Virtual Screening and Molecular Dynamics Study on Blockage of Key Drug Targets as Treatment for COVID-19 caused by SARS-CoV-2
19
Virtual Screening of Natural Products, Molecular Docking and Dynamics Simulations on M.tuberculosis S-adenosyl-L-homocysteine Hydrolase
7
IN-SILICO APPROACH FOR THE IDENTIFICATION OF NEW MOLECULES FOR ALZHEIMER’S DISEASE (AD)
16
Computational Modeling on Aquaporin-3 as Skin Cancer Target: A Virtual Screening and Molecular Dynamic Simulation Study
30
High-throughput virtual screening with e-pharmacophore and molecular simulations study in the designing of pancreatic lipase inhibitors
16
DESIGN, SYNTHESIS AND VIRTUAL SCREENING OF CERTAIN 2 PYRAZOLIN 5 ONE AND PYRAZOLIDINE 3, 5 DIONE DERIVATIVES AS POTENTIAL PPAR AGONISTS
12
Pharmacoinformatic and molecular docking studies reveal potential novel antidepressants against neurodegenerative disorders by targeting HSPB8
14
Structure-Based Design of Inhibitors Against Maltosyltransferase Glge
9
In silico identification of novel ligand molecules for rabies nucleoprotein using structure-based method.
6
IVSPlat 1.0: an integrated virtual screening platform with a molecular graphical interface
10
3D Pharmacophore-based Virtual Screening, Docking Approaches toward the Discovery of Novel HPPD Inhibitors
14
CVDHD: a cardiovascular disease herbal database for drug discovery and network pharmacology
6
Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity
16
In silico discovery and in vitro activity of inhibitors against <em>Mycobacterium tuberculosis</em> 7,8-diaminopelargonic acid synthase (<em>Mtb</em> BioA)
12
INSILICO PHARMACOPHORE ANALYSIS OF POTENTIAL INHIBITORS TO TREAT THE COMPLICATIONS OF EMERGING INFECTIOUS BOURBON VIRUS
14